These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 467503)

  • 1. Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
    Hofmann M; Battaini F; Tonon G; Trabucchi M; Spano P
    Eur J Pharmacol; 1979 Jun; 56(1-2):15-20. PubMed ID: 467503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
    Delitala G
    Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release?
    Soares-da-Silva P
    J Pharm Pharmacol; 1987 Feb; 39(2):127-9. PubMed ID: 2881997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogenetic changes in dopaminergic pre and postsynaptic elements in rat brain: effects of quinpirole and sulpiride.
    McDougall SA; Bardo MT
    Neuropharmacology; 1991 May; 30(5):531-4. PubMed ID: 1678147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of metergoline with striatal dopamine system.
    Spano PF; Biggio G; Casu M; Gessa GL; Bareggi SR; Govoni S; Trabucchi M
    Life Sci; 1978 Dec; 23(24):2383-91. PubMed ID: 745518
    [No Abstract]   [Full Text] [Related]  

  • 6. Repeated atypical neuroleptic administration: effects on central dopamine metabolism monitored by in vivo voltammetry.
    Maidment NT; Marsden CA
    Eur J Pharmacol; 1987 Apr; 136(2):141-9. PubMed ID: 3595718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine enhances feeding behavior without changing dopamine metabolism.
    Inoue K; Kiriike N; Kurioka M; Fujisaki Y; Iwasaki S; Yamagami S
    Pharmacol Biochem Behav; 1997 Sep; 58(1):183-8. PubMed ID: 9264089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.
    de Belleroche J; Gardiner IM
    J Neural Transm; 1983; 58(3-4):153-68. PubMed ID: 6141217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased self-administration of d-amphetamine by rats pretreated with metergoline.
    Lyness WH; Moore KE
    Pharmacol Biochem Behav; 1983 May; 18(5):721-4. PubMed ID: 6190187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of penfluridol on circling behavior and striatal DOPAC and serum prolactin concentrations in the rat.
    Annunziato LA; Wuerthele SM; Moore KE
    Eur J Pharmacol; 1978 Aug; 50(3):187-92. PubMed ID: 567584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo dialysis measurements of dopamine and DOPAC in rats trained to turn on a circular treadmill.
    Sabol KE; Richards JB; Freed CR
    Pharmacol Biochem Behav; 1990 May; 36(1):21-8. PubMed ID: 2349264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
    Bohnet HG; Kato K; De Moll H
    Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
    Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
    Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
    [No Abstract]   [Full Text] [Related]  

  • 14. Metergoline and cyproheptadine suppress prolactin release by a non-5-hydroxytryptaminergic, non-dopaminergic mechanism.
    Besser GM; Delitala G; Grossman A; Yeo T
    Br J Pharmacol; 1980 Sep; 70(1):5-7. PubMed ID: 7426830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophysectomy does not prevent increased cerebral dopamine turnover following sulpiride administration.
    Reynolds LM; Dyer RG; Jenner P; Marsden CD
    J Pharm Pharmacol; 1983 Mar; 35(3):170-4. PubMed ID: 6132975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.
    Ferrari C; Caldara R; Rampini P; Telloli P; Romussi M; Bertazzoni A; Polloni G; Mattei A; Crosignani PG
    Metabolism; 1978 Oct; 27(10):1499-504. PubMed ID: 692379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.
    Flückiger E; Briner U; Bürki HR; Marbach P; Wagner HR; Doepfner W
    Experientia; 1979 Dec; 35(12):1677-8. PubMed ID: 520501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
    Delitala G; Masala A; Alagna S; Devilla L; Lotti G
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1382-6. PubMed ID: 1002821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-dihydroxyphenylacetic acid (DOPAC) and the rat mesolimbic dopaminergic pathway: drug effects and evidence for somatodendritic mechanisms.
    Beart PM; Gundlach AL
    Br J Pharmacol; 1980 Jun; 69(2):241-7. PubMed ID: 6108139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.